{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-016794","form_type":"8-K","ticker":"ESPR","cik":"0001434868","company_name":"Esperion Therapeutics, Inc.","filed_at":"2025-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.286430+00:00","generated_at":"2026-05-23T20:48:52.452720+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Esperion CCO Eric Warren to depart effective April 18, 2025","bullets":["Eric Warren stepping down as Chief Commercial Officer, effective April 18, 2025.","Departure not the result of any disagreement with the Company on operations, policies, or practices.","No successor or interim CCO announced in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-016794","json":"https://secwatch.observer/filing/0001628280-25-016794.json","markdown":"https://secwatch.observer/filing/0001628280-25-016794.md","text":"https://secwatch.observer/filing/0001628280-25-016794.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025016794/0001628280-25-016794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025016794/espr-20250404.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T20:48:52.452720+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cfbc427d92","claim":"Eric Warren departed as Chief Commercial Officer at Esperion Therapeutics, Inc..","evidence_excerpt":"Eric Warren was stepping down from his position as Chief Commercial Officer of the Company, effective as of April 18, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025016794/0001628280-25-016794-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepping down"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}